Brief: Tiziana Life Sciences Files Investigational New Drug Application With FDA For ALS Phase 2 Clinical Trial
04/03/2025 13:22
March 4 (Reuters) - Tiziana Life Sciences Ltd TLSA.O: TIZIANA LIFE SCIENCES FILES INVESTIGATIONAL NEW DRUG APPLICATION WITH FDA FOR ALS PHASE 2 CLINICAL TRIAL Source text: ID:nGNX4JkHLT Further company coverage: TLSA.O (Reuters.Briefs@thomsonreuters.com)
Recent news on Tiziana Life Sciences
See all newsBrief: Tiziana Announces New Positive Clinical Data For Intranasal Foralumab In Non-Active Secondary Progressive Multiple Sclerosis
U.S. STOCKS ON THE MOVE -Viatris, Clear Secure, Bicara
U.S. STOCKS ON THE MOVE-Sharps Technology, Whirlpool, Applovin
U.S. STOCKS ON THE MOVE-Oracle, Vanda, Keysight
Tiziana Life Sciences rises as nasal MS drug shows promise in early study